Woman Given Dire Cancer Prognosis After Doctors Dismissed Her Stomach Symptoms as Heartburn "In that room, my whole world crumbled," Georgia-Leigh Gardiner said of the moment she was diagnosed ...

I-Mab reported positive Phase 1b study results for givastomig in metastatic gastric cancers, highlighting significant efficacy and a favorable safety profile.

Michelle Rusch served with LMPD for more than a decade as member of the Crimes Against Children Unit. She died June 10 from stomach cancer.

Key Takeaways An immunotherapy drug can boost survival in people with stomach or esophageal cancerWhen combined with chemo, durvalumab eliminated cancer in nearly 1 in 5 patientsAfter two years ...

For patients with resectable gastric or gastroesophageal junction adenocarcinoma, durvalumab plus fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) yields better event-free survival ...

AstraZeneca’s immunotherapy Imfinzi has proven it can help certain patients with early-stage stomach cancer, according to results from a phase 3 study. | AstraZeneca’s Imfinzi has proven it ...

Perioperative FLOT (fluorouracil, leucovorin, oxaliplatin, and docetaxel) is a standard therapy for resectable gastric and gastroesophageal junction adenocarcinomas, but recurrence rates remain hig ...

On the basis of phase 2 studies, trastuzumab deruxtecan was approved for patients with human epidermal growth factor receptor 2 (HER2)–positive metastatic gastric cancer or gastroesophageal ...

News Dallas scientists developing light-activated treatment for late-stage stomach cancer Antibody-like molecules called betabodies might be the key to treating peritoneal carcinomatosis.

Ben Rathbun, known from "90 Day Fiancé," has died after battling Stage 4 stomach cancer, surrounded by family in Indiana.

About Power of Purple Power of Purple is a nonprofit organization dedicated to raising awareness of esophageal and gastric cancers through the power of design.

Gastric Cancer: The Basics of Diagnosis, Staging, and Treatment — Treatment advances offer hope, but early diagnosis remains a challenge ...